Company intelligence / Profile preview

Silvia Health

Ownership: Private
Development stage: Commercial

Overview

Silvia Health has developed a mobile application that provides personalized brain care solutions to reduce the risk of dementia by early detection and management of cognitive health. A 2022 study showed users had a 17% improvement in memory scores compared to controls. The company is conducting clinical research with Indiana University and Chosun University hospitals to further validate its effectiveness

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapyDeviceSoftware medical device
Industry: Digital Health Medical Devices

Drug pipeline

3 assets

Silvia

Commercial

Indications: Cognitive health monitoring

2 more assets in the full pipeline.

Request access →

Partnerships

Indiana University Hospital (clinical research)Chosun University Hospital (clinical research)

Beyond the preview

Go deeper on Silvia Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silvia Health.

Explore the full profile